AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 257 filers reported holding AXSOME THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 1.16 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,663,774 | +5.0% | 20,668 | +4.1% | 0.00% | 0.0% |
| Q1 2024 | $1,584,429 | +27.7% | 19,855 | +27.3% | 0.00% | 0.0% |
| Q4 2023 | $1,240,967 | +11.4% | 15,592 | -2.2% | 0.00% | 0.0% |
| Q3 2023 | $1,113,907 | +19.9% | 15,938 | +23.3% | 0.00% | – |
| Q2 2023 | $929,150 | +43.8% | 12,930 | +23.5% | 0.00% | – |
| Q1 2023 | $645,975 | -30.3% | 10,473 | -12.9% | 0.00% | – |
| Q4 2022 | $927,180 | +40.5% | 12,021 | -18.7% | 0.00% | – |
| Q3 2022 | $660,000 | +59.0% | 14,781 | +36.5% | 0.00% | – |
| Q2 2022 | $415,000 | +29.7% | 10,832 | +40.2% | 0.00% | – |
| Q1 2022 | $320,000 | -4.5% | 7,728 | -12.8% | 0.00% | – |
| Q4 2021 | $335,000 | -16.5% | 8,858 | -27.2% | 0.00% | – |
| Q3 2021 | $401,000 | -48.9% | 12,166 | +4.6% | 0.00% | – |
| Q2 2021 | $785,000 | +49.0% | 11,635 | +25.1% | 0.00% | – |
| Q1 2021 | $527,000 | – | 9,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 991,754 | $58,345,000 | 37.79% |
| VR Adviser, LLC | 810,000 | $47,652,000 | 12.91% |
| ACUTA CAPITAL PARTNERS, LLC | 308,500 | $18,149,000 | 8.80% |
| Fairmount Funds Management LLC | 189,598 | $11,154,000 | 6.76% |
| RA Capital Management | 1,904,094 | $112,018,000 | 3.54% |
| Ghost Tree Capital, LLC | 215,000 | $12,648,000 | 3.36% |
| MORGAN JESS S & CO INC | 42,402 | $2,495,000 | 3.24% |
| RTW INVESTMENTS, LP | 1,052,969 | $61,946,000 | 2.67% |
| EAM Global Investors LLC | 50,649 | $2,980,000 | 1.74% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,172,014 | $68,950,000 | 1.67% |